$P

Colgrove John sold $22.6M of P (indirect holdings)

Colgrove John (Chief Visionary Officer) sold 235,185 indirectly-held shares of Everpure, Inc. (P) at an average of $95.94 ($90.01–$101.59, $22.56M total) across 22 trades over 2026-08-07 to 2026-08-10 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Colgrove John
Published Aug 11, 2026, 9:57 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 11, 2026, 10:01 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$P
Neutral
medium confidence
Mentioned
$P
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$PNeutralLow
01

Why it matters

Colgrove John, an officer/director (Chief Visionary Officer), executed an open-market sale totaling about $22.56M across 22 trades, with a weighted average price of $95.9374, under a pre-arranged 10b5-1 plan.

02

Market read

Traders may monitor for sentiment effects from insider selling, but there is no new company-specific fundamental catalyst in the text.

03

What to watch

The article does not clarify whether the indirect holdings are held through entities with different tax or liquidity needs, nor does it provide any offsetting purchases.

Relevance 6/10Novelty 5/10Timing: filed Aug 11, covering sales from Aug 7 to Aug 10

Background

The article is an SEC Form 4 insider transaction filing for Everpure, Inc. (issuer code P).

Company-level read

Ticker impact

$PNeutralMedium confidence
Context

Everpure’s Form 4 shows officer Colgrove John sold $22.56M of P via an open-market sale under a 10b5-1 plan (235,185 shares).

Expected impact

Low likelihood of a sustained price move; any reaction is likely limited to short-term sentiment around insider selling.

Evidence & confidence

The filing is a primary SEC Form 4 datapoint with transaction size and timing, but it does not include new operating, financial, or regulatory information about Everpure.

Market effects

No sector-level implications are disclosed; this is a single-company insider transaction.

None indicated.

None indicated.

Counterpoint

Because the sale is under a pre-arranged 10b5-1 plan, the signal may be weaker than typical insider selling and could be largely mechanical.

Key entities

  • Everpure, Inc.

    Subject of the Form 4 insider transaction disclosure (ticker P).

  • Colgrove John

    Chief Visionary Officer, officer and director; sold shares via an open-market sale under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$PHighAI 8/10

Everpure (P) Shares Rise After CFRA Upgrade and Strong Fiscal 20

Everpure Inc (NYSE: P) shares rose 3% after CFRA upgraded it from Sell to Buy, citing raised guidance for fiscal 2028. The company projects $7B-$7.3B in revenue and $1.7B-$1.9B in non-GAAP operating income, driven by demand for its all-flash storage solutions in AI data centers. Despite this, GuruFocus's GF Value™ suggests the stock is overvalued at $126.00, with an intrinsic value of $81.40.

$METAMedAI 8/10

Meta, Everpure, Akamai Technologies, Apimeds Pharmaceuticals and Costco: Why These 5 Stocks Are on Invest

Meta (META) rose 4.5% to $777.59, driven by AI strategy. Everpure (P) surged 11.15% to $121.88, reaffirming fiscal 2027 guidance. Akamai (AKAM) fell 6.78% to $110.41, then jumped 20.65% after-hours on a $11.6B AI deal. Apimeds (APUS) soared 114.85% to $4.92 on a blockchain agreement. Costco (COST) dipped 0.91% to $896.48 despite beating Q4 estimates.

$PHighAI 8/10

Everpure Stock Jumps As S&P 500 Inclusion Fuels Momentum

Everpure Inc. (NYSE: P) stock rose 12.77% after its inclusion in the S&P 500. The company's shares have climbed from the low-$90s to $121.88, with a high of $131.41. Everpure reported $3.66B in annual revenue, 70.2% gross margins, and a P/E above 380. The S&P 500 inclusion is expected to drive passive fund buying.

$PMed

Needham raises Everpure stock price target on strong FY28 outlook

Needham raised its price target for Everpure (NYSE:P) to $150 from $140, maintaining a Buy rating. The firm cited Everpure's strong fiscal 2028 outlook, with projected revenue growth of 39% to 45% and operating margins of 24% to 26%. The company also reported second-quarter fiscal 2027 revenue of $1.186 billion, up 38% year-over-year. Several analysts have revised earnings upwards, and the stock has returned 68.3% over the last six months.